Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice

Justina E. Wu, Federica Basso, Robert D. Shamburek, Marcelo J A Amar, Boris Vaisman, G. Szakács, Charles Joyce, Terese Tansey, Lita Freeman, Beverly J. Paigen, Fairwell Thomas, H. Bryan Brewer, Silvia Santamarina-Fojo

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The individual roles of hepatic versus intestinal ABCG5 and ABCG8 in sterol transport have not yet been investigated. To determine the specific contribution of liver ABCG5/G8 to sterol transport and atherosclerosis, we generated transgenic mice that overexpress human ABCG5 and ABCG8 in the liver but not intestine (liver G5/G8-Tg) in three different genetic backgrounds: C57Bl/6, apoE-KO, and low density lipoprotein receptor (LDLr)-KO. Hepatic overexpression of ABCG5/G8 enhanced hepatobiliary secretion of cholesterol and plant sterols by 1.5-2-fold, increased the amount of intestinal cholesterol available for absorption and fecal excretion by up to 27%, and decreased the accumulation of plant sterols in plasma by ∼25%. However, it did not alter fractional intestinal cholesterol absorption, fecal neutral sterol excretion, hepatic cholesterol concentrations, or hepatic cholesterol synthesis. Consequently, overexpression of ABCG5/G8 in only the liver had no effect on the plasma lipid profile, including cholesterol, HDL-C, and non-HDL-C, or on the development of proximal aortic atherosclerosis in C57Bl/6, apoE-KO, or LDLr-KO mice. Thus, liver ABCG5/G8 facilitate the secretion of liver sterols into bile and serve as an alternative mechanism, independent of intestinal ABCG5/G8, to protect against the accumulation of dietary plant sterols in plasma. However, in the absence of changes in fractional intestinal cholesterol absorption, increased secretion of sterols into bile induced by hepatic overexpression of ABCG5/G8 was not sufficient to alter hepatic cholesterol balance, enhance cholesterol removal from the body or to alter atherogenic risk in liver G5/ G8-Tg mice. These findings demonstrate that overexpression of ABCG5/G8 in the liver profoundly alters hepatic but not intestinal sterol transport, identifying distinct roles for liver and intestinal ABCG5/G8 in modulating sterol metabolism.

Original languageEnglish
Pages (from-to)22913-22925
Number of pages13
JournalJournal of Biological Chemistry
Volume279
Issue number22
DOIs
Publication statusPublished - May 28 2004

Fingerprint

Sterols
Liver
Transgenic Mice
Atherosclerosis
Cholesterol
Phytosterols
LDL Receptors
Apolipoproteins E
Plasmas
Intestinal Absorption
Bile
Metabolism
HDL Cholesterol
Lipids
Intestines

ASJC Scopus subject areas

  • Biochemistry

Cite this

Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. / Wu, Justina E.; Basso, Federica; Shamburek, Robert D.; Amar, Marcelo J A; Vaisman, Boris; Szakács, G.; Joyce, Charles; Tansey, Terese; Freeman, Lita; Paigen, Beverly J.; Thomas, Fairwell; Brewer, H. Bryan; Santamarina-Fojo, Silvia.

In: Journal of Biological Chemistry, Vol. 279, No. 22, 28.05.2004, p. 22913-22925.

Research output: Contribution to journalArticle

Wu, JE, Basso, F, Shamburek, RD, Amar, MJA, Vaisman, B, Szakács, G, Joyce, C, Tansey, T, Freeman, L, Paigen, BJ, Thomas, F, Brewer, HB & Santamarina-Fojo, S 2004, 'Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice', Journal of Biological Chemistry, vol. 279, no. 22, pp. 22913-22925. https://doi.org/10.1074/jbc.M402838200
Wu, Justina E. ; Basso, Federica ; Shamburek, Robert D. ; Amar, Marcelo J A ; Vaisman, Boris ; Szakács, G. ; Joyce, Charles ; Tansey, Terese ; Freeman, Lita ; Paigen, Beverly J. ; Thomas, Fairwell ; Brewer, H. Bryan ; Santamarina-Fojo, Silvia. / Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. In: Journal of Biological Chemistry. 2004 ; Vol. 279, No. 22. pp. 22913-22925.
@article{cf69dd0986c84961bfa69a2367f92074,
title = "Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice",
abstract = "The individual roles of hepatic versus intestinal ABCG5 and ABCG8 in sterol transport have not yet been investigated. To determine the specific contribution of liver ABCG5/G8 to sterol transport and atherosclerosis, we generated transgenic mice that overexpress human ABCG5 and ABCG8 in the liver but not intestine (liver G5/G8-Tg) in three different genetic backgrounds: C57Bl/6, apoE-KO, and low density lipoprotein receptor (LDLr)-KO. Hepatic overexpression of ABCG5/G8 enhanced hepatobiliary secretion of cholesterol and plant sterols by 1.5-2-fold, increased the amount of intestinal cholesterol available for absorption and fecal excretion by up to 27{\%}, and decreased the accumulation of plant sterols in plasma by ∼25{\%}. However, it did not alter fractional intestinal cholesterol absorption, fecal neutral sterol excretion, hepatic cholesterol concentrations, or hepatic cholesterol synthesis. Consequently, overexpression of ABCG5/G8 in only the liver had no effect on the plasma lipid profile, including cholesterol, HDL-C, and non-HDL-C, or on the development of proximal aortic atherosclerosis in C57Bl/6, apoE-KO, or LDLr-KO mice. Thus, liver ABCG5/G8 facilitate the secretion of liver sterols into bile and serve as an alternative mechanism, independent of intestinal ABCG5/G8, to protect against the accumulation of dietary plant sterols in plasma. However, in the absence of changes in fractional intestinal cholesterol absorption, increased secretion of sterols into bile induced by hepatic overexpression of ABCG5/G8 was not sufficient to alter hepatic cholesterol balance, enhance cholesterol removal from the body or to alter atherogenic risk in liver G5/ G8-Tg mice. These findings demonstrate that overexpression of ABCG5/G8 in the liver profoundly alters hepatic but not intestinal sterol transport, identifying distinct roles for liver and intestinal ABCG5/G8 in modulating sterol metabolism.",
author = "Wu, {Justina E.} and Federica Basso and Shamburek, {Robert D.} and Amar, {Marcelo J A} and Boris Vaisman and G. Szak{\'a}cs and Charles Joyce and Terese Tansey and Lita Freeman and Paigen, {Beverly J.} and Fairwell Thomas and Brewer, {H. Bryan} and Silvia Santamarina-Fojo",
year = "2004",
month = "5",
day = "28",
doi = "10.1074/jbc.M402838200",
language = "English",
volume = "279",
pages = "22913--22925",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "22",

}

TY - JOUR

T1 - Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice

AU - Wu, Justina E.

AU - Basso, Federica

AU - Shamburek, Robert D.

AU - Amar, Marcelo J A

AU - Vaisman, Boris

AU - Szakács, G.

AU - Joyce, Charles

AU - Tansey, Terese

AU - Freeman, Lita

AU - Paigen, Beverly J.

AU - Thomas, Fairwell

AU - Brewer, H. Bryan

AU - Santamarina-Fojo, Silvia

PY - 2004/5/28

Y1 - 2004/5/28

N2 - The individual roles of hepatic versus intestinal ABCG5 and ABCG8 in sterol transport have not yet been investigated. To determine the specific contribution of liver ABCG5/G8 to sterol transport and atherosclerosis, we generated transgenic mice that overexpress human ABCG5 and ABCG8 in the liver but not intestine (liver G5/G8-Tg) in three different genetic backgrounds: C57Bl/6, apoE-KO, and low density lipoprotein receptor (LDLr)-KO. Hepatic overexpression of ABCG5/G8 enhanced hepatobiliary secretion of cholesterol and plant sterols by 1.5-2-fold, increased the amount of intestinal cholesterol available for absorption and fecal excretion by up to 27%, and decreased the accumulation of plant sterols in plasma by ∼25%. However, it did not alter fractional intestinal cholesterol absorption, fecal neutral sterol excretion, hepatic cholesterol concentrations, or hepatic cholesterol synthesis. Consequently, overexpression of ABCG5/G8 in only the liver had no effect on the plasma lipid profile, including cholesterol, HDL-C, and non-HDL-C, or on the development of proximal aortic atherosclerosis in C57Bl/6, apoE-KO, or LDLr-KO mice. Thus, liver ABCG5/G8 facilitate the secretion of liver sterols into bile and serve as an alternative mechanism, independent of intestinal ABCG5/G8, to protect against the accumulation of dietary plant sterols in plasma. However, in the absence of changes in fractional intestinal cholesterol absorption, increased secretion of sterols into bile induced by hepatic overexpression of ABCG5/G8 was not sufficient to alter hepatic cholesterol balance, enhance cholesterol removal from the body or to alter atherogenic risk in liver G5/ G8-Tg mice. These findings demonstrate that overexpression of ABCG5/G8 in the liver profoundly alters hepatic but not intestinal sterol transport, identifying distinct roles for liver and intestinal ABCG5/G8 in modulating sterol metabolism.

AB - The individual roles of hepatic versus intestinal ABCG5 and ABCG8 in sterol transport have not yet been investigated. To determine the specific contribution of liver ABCG5/G8 to sterol transport and atherosclerosis, we generated transgenic mice that overexpress human ABCG5 and ABCG8 in the liver but not intestine (liver G5/G8-Tg) in three different genetic backgrounds: C57Bl/6, apoE-KO, and low density lipoprotein receptor (LDLr)-KO. Hepatic overexpression of ABCG5/G8 enhanced hepatobiliary secretion of cholesterol and plant sterols by 1.5-2-fold, increased the amount of intestinal cholesterol available for absorption and fecal excretion by up to 27%, and decreased the accumulation of plant sterols in plasma by ∼25%. However, it did not alter fractional intestinal cholesterol absorption, fecal neutral sterol excretion, hepatic cholesterol concentrations, or hepatic cholesterol synthesis. Consequently, overexpression of ABCG5/G8 in only the liver had no effect on the plasma lipid profile, including cholesterol, HDL-C, and non-HDL-C, or on the development of proximal aortic atherosclerosis in C57Bl/6, apoE-KO, or LDLr-KO mice. Thus, liver ABCG5/G8 facilitate the secretion of liver sterols into bile and serve as an alternative mechanism, independent of intestinal ABCG5/G8, to protect against the accumulation of dietary plant sterols in plasma. However, in the absence of changes in fractional intestinal cholesterol absorption, increased secretion of sterols into bile induced by hepatic overexpression of ABCG5/G8 was not sufficient to alter hepatic cholesterol balance, enhance cholesterol removal from the body or to alter atherogenic risk in liver G5/ G8-Tg mice. These findings demonstrate that overexpression of ABCG5/G8 in the liver profoundly alters hepatic but not intestinal sterol transport, identifying distinct roles for liver and intestinal ABCG5/G8 in modulating sterol metabolism.

UR - http://www.scopus.com/inward/record.url?scp=2542427448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542427448&partnerID=8YFLogxK

U2 - 10.1074/jbc.M402838200

DO - 10.1074/jbc.M402838200

M3 - Article

C2 - 15044450

AN - SCOPUS:2542427448

VL - 279

SP - 22913

EP - 22925

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 22

ER -